KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF.

Eur Heart J Cardiovasc Pharmacother · 2025-Nov-04 · PMID 40839760

Panel G质量警告待 EXE 对齐验证

CV Death or First HF Hospitalization

Figure 4 Cumulative incidence of the composite outcome according to baseline EuroQol Five-dimension Three-level (EQ-5D-3L) Questionnaire. ( A ) ‘Mobility’ domain; ( B ) ‘self-care’ domain; ( C ) ‘usual activities’ domain; ( D ) ‘pain/discomfort’ domain; ( E ) ‘anxiety/depression’ domain; ( F ) Level Sum Score (LSS) category divided by tertile; ( G ) Visual Analog Scale (VAS) category divided by tertile. The patients reported ‘Some problem’ and ‘Extreme problem’ were combined into one group due to a small number in the worst category of ‘mobility’ domain ( n = 27) and ‘self-care’ domain ( n = 73). CV, cardiovascular; HF, heart failure.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分1.00
质量通过否
预期曲线3
实际曲线2
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证22026-07-23T17:57:56+00:00